Back
Relay Therapeutics Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
18
RLAY
Relay Therapeutics
Last Price:
4.71
Seasonality Move:
-6.4%
Buy
57
BMRN
Biomarin Pharmaceutical
Last Price:
63.28
Seasonality Move:
12.47%
Sell
18
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics a Buy, Sell or Hold?
- The current Relay Therapeutics [RLAY] share price is $4.66. The Score for RLAY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- RLAY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
57
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $62.56. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RLAY Stock Price Chart
What is Relay Therapeutics's stock price today?
-
The Relay Therapeutics share price today is $4.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $62.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
RLAY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 23.85 | Sell |
Chaikin Money Flow: | 194739 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.35 - 6.45) | Sell |
Bollinger Bands (100): | (5.96 - 8) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.16 | Sell |
Relative Strength Index (14 RSI): | 27.46 | Sell |
Chaikin Money Flow: | 863717 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (64.41 - 69.77) | Sell |
Bollinger Bands (100): | (68.48 - 87.38) | Sell |
RLAY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.37 | Sell |
20-day SMA: | 5.73 | Sell |
50-day SMA: | 6.5 | Sell |
200-day SMA: | 7.36 | Sell |
8-day EMA: | 5.22 | Sell |
20-day EMA: | 5.69 | Sell |
50-day EMA: | 6.26 | Sell |
200-day EMA: | 7.52 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.33 | Sell |
20-day SMA: | 66.31 | Sell |
50-day SMA: | 69.39 | Sell |
200-day SMA: | 81.31 | Sell |
8-day EMA: | 63.89 | Sell |
20-day EMA: | 65.94 | Sell |
50-day EMA: | 70.23 | Sell |
200-day EMA: | 79.7 | Sell |
Relay Therapeutics Earnings Growth & RLAY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.02 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Relay Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |